Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Deciphera Pharmaceuticals, Inc. (DCPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,942 shares @ $12.68, valued at $37.3k
06/12/2023 4 Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $13.8828, valued at $138.8k
03/23/2023 4 Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 7,500 shares @ $15.5709, valued at $116.8k
03/01/2023 4 Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 2,427,693 warrants @ $0.01, valued at $24.3k
01/24/2023 4 Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Bought 1,666,666 shares @ $18, valued at $30M
01/19/2023 4 Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
01/19/2023 4 Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,403 shares @ $21.2413, valued at $51k
01/19/2023 4 Pitman Jama (See Remarks) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,603 shares @ $21.2413, valued at $34k
01/19/2023 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,403 shares @ $21.2413, valued at $51k
01/19/2023 4 Allen Patricia L (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
01/19/2023 4 Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,603 shares @ $21.2413, valued at $34k
01/19/2023 4 Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,403 shares @ $21.2413, valued at $51k
01/19/2023 4 Walsh Dennis Leo (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
01/19/2023 4 Squarer Ron (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
01/19/2023 4 Kelley Susan L. (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
10/05/2022 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,587 shares @ $18.73, valued at $48.5k
06/24/2022 4 Walsh Dennis Leo (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 18,500 options to buy @ $13.98, valued at $258.6k
06/24/2022 4 Bristol James Arthur (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 18,500 options to buy @ $13.98, valued at $258.6k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Martin John Richard (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 18,500 options to buy @ $13.98, valued at $258.6k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Benz Edward J. JR (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 18,500 options to buy @ $13.98, valued at $258.6k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Pitman Jama (See Remarks) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,298 shares @ $10.75, valued at $14k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Kelly Thomas Patrick (CFO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,768 shares @ $10.75, valued at $19k
06/21/2022 4 Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,768 shares @ $10.75, valued at $19k
04/29/2022 4 Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Bought 1,478,978 shares @ $10, valued at $14.8M
Bought 3,389,830 warrants @ $0.01, valued at $33.9k
03/23/2022 4 Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 3,150 shares @ $9.11, valued at $28.7k
02/18/2022 4 Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,366 shares @ $9.05, valued at $12.4k
02/18/2022 4 Martin Daniel C. (Chief Commercial Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,146 shares @ $9.05, valued at $10.4k
02/18/2022 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 984 shares @ $9.05, valued at $8.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy